High-throughput genetic screening of T cells is conducted through TCR stimulation with anti-CD3/CD28 and IL-2, co-culturing with tumor cells (in vitro), or implantation in tumor-bearing mice (in vivo). The gene discussed is IL2; the disease is neoplasm.